Advanced Flower Capital Earnings Call Transcripts
Fiscal Year 2026
-
The meeting established a quorum and proceeded with the reelection of two directors and the ratification of the independent auditor. All proposals passed, with final results to be filed with the SEC.
-
First quarter as a BDC saw $90M in new non-cannabis commitments and $9.8M total investment income. Net asset value per share rose to $7.90, with a $5M share buyback and expanded credit facility supporting growth.
Fiscal Year 2025
-
Focused on reducing underperforming credit exposure and completed a REIT-to-BDC conversion, expanding investment flexibility. FY 2025 saw $24.6M net interest income, $8.7M distributable earnings, and a $20.7M GAAP net loss, with a strong $1.4B pipeline post-conversion.
-
Shareholders approved conversion to a BDC, expanding the investment universe beyond cannabis and real estate. Q3 saw $0.16 distributable earnings per share and a $12.5M GAAP net loss, with no Q4 dividend expected due to a $4M loan loss.
-
Announced plan to convert from REIT to BDC to expand lending beyond real estate-backed cannabis operators, aiming for greater diversification and improved returns. Q2 2025 saw $3.4M distributable earnings, a $13.2M GAAP net loss, and continued focus on managing underperforming loans.
-
Q1 2025 saw distributable earnings of $0.21 per share and a portfolio yield of 18%, with muted originations due to market volatility and a selective lending approach. Asset liquidations and legal proceedings continue to impact recovery timing, while a renewed $100M credit facility supports future growth.
Fiscal Year 2024
-
Surpassed 2024 origination goals with $135M in new cannabis loans, actively managed underperforming credits, and maintained a robust pipeline exceeding $380M. Q4 distributable earnings were $0.29 per share, with a sustainable dividend set at $0.23 per share.
-
Surpassed $100 million in annual loan originations, operating as a pure-play cannabis lender with an 18% portfolio yield. Maintains strong liquidity and capital position, with a cautious outlook amid slow federal reform and limited competition from traditional lenders.
-
Completed spin-off to become a pure-play cannabis lender, reporting strong Q2 results with $11.4M distributable earnings and a 19% portfolio yield. Exited major loans at attractive IRRs, maintained robust liquidity, and reaffirmed dividend policy.